1.Superficial Epithelioma with Sebaceous Differentiation Presented as a Yellow Plaque.
Hye Jin LEE ; Ju Yun WOO ; You Won CHOI ; Hae Young CHOI ; Ji Yeon BYUN
Annals of Dermatology 2017;29(4):516-518
No abstract available.
Carcinoma*
2.Epithelioma Cuniculatum Arising from Striate Keratoderma.
Wook LEW ; Kwan Chul TARK ; Soo Il CHUN
Annals of Dermatology 1992;4(2):83-86
No abstract available.
Carcinoma*
3.A Case of Superficial Epithelioma with Sebaceous Differentiation.
Jae Kyung KIM ; Ji Su HAN ; Chong Hyun WON ; Sung Eun CHANG ; Mi Woo LEE ; Jee Ho CHOI ; Kee Chan MOON
Korean Journal of Dermatology 2012;50(5):483-484
No abstract available.
Carcinoma
4.The utility of ultrasound-guided tru-cut biopsy in the diagnosis of occult breast carcinoma presenting as ovarian malignancy with multiple metastases: A case of unknown primary
Kareen N. Reforma ; Maria Julieta V. Germar
Acta Medica Philippina 2023;57(11):92-96
This paper documents the utility of ultrasound-guided tru-cut biopsy in the diagnosis and subsequent management of a case of occult breast carcinoma presenting with multiple distant metastases in the absence of a primary breast lesion. She was initially diagnosed as primary ovarian malignancy with metastatic disease and subsequently underwent transvaginal ultrasound-guided tru-cut biopsy of the right ovarian mass. Histologic and immunohistochemical studies were consistent with a metastatic adenocarcinoma of breast origin. The patient underwent chemotherapy for primary breast carcinoma and has responded well.
Carcinoma
5.Basosquamous carcinoma of the neck
Jan Warren A. Holgado ; Joseph E. Cachuela
Philippine Journal of Otolaryngology Head and Neck Surgery 2011;26(1):46-48
Basosquamous carcinoma, a variant of basal cell carcinoma, is rather rare with an incidence of only 1 – 2% of cases. 1, 2 It has a predilection for the head and neck region (95.6%) with primary sites including the nasal, auricular and periocular area with the neck involved in only 1.1%.1 Unlike typical basal cell carcinoma, basosquamous carcinoma behaves more aggressively with a higher tendency for metastasis and recurrence. Its rarity translates to a lack of management guidelines. Because of its pattern of growth and relative aggressiveness, treatment plans must be well laid; recurrence resulting from poor planning may lead to a worse outcome and poorer prognosis.
Carcinoma
6.Hyalinizing clear cell carcinoma of the salivary gland in an elderly female: A case report supported by EWSR1 molecular studies
Ariane Marielle F. Valle ; Jose Louie D. Remotigue ; Erick Martin H. Yturralde ; Jose M. Carnate Jr.
Acta Medica Philippina 2024;58(Early Access 2024):1-4
Hyalinizing clear cell carcinoma of the salivary gland is a rare neoplasm, accounting for only less than 1% of malignancies arising from the salivary gland. It is molecularly defined by the expression of the EWSR-ATF1 fusion oncogene. To date, there has been no previous studies published yet in the Philippines regarding the existence of this tumor. In this paper, we present a case of a 70-year-old elderly female who had a 10-year history of a gradually enlarging left lateral neck mass. Histopathologic examination showed a tumor arranged of cords, nests, and trabeculae of monomorphic round cells with abundant clear to lightly eosinophilic cytoplasm surrounded by thick hyalinized collagen bundles. Immunohistochemistry and molecular studies were done which revealed a positive p63 staining, negative SMA and S100, and an EWSR1 rearrangement in Fluorescence in situ hybridization (FISH), thus, confirming the diagnosis.
Carcinoma
7.Application of Argyrophilic Nucleolar Organizer Regions(AgNORs) in the Diagnosi of Hepatocellular Carcinoma.
Cheol Hee YUN ; Sang Sook LEE ; Eun Sook CHANG
Korean Journal of Pathology 1993;27(6):553-560
Necleolar organizer regions(NORs) ARE LOOPS OF DNA which transcribe to ribosomal RNA by RNA polymerase I. Since NOR-associated proteins are argyrophilic, silver staining method has been used for demonstration of AgNORs. The numbers and/or configurations of NORs may reflect the activities of cells in hyperplastic and neoplastic conditions. To evaluated the applicability of AgNORs in the diagnosis of hepatocellular carcinoma, the author had performed silver staining on the routinely processed, formalin-fixed, paraffin-embedded sections of 14 cases of normal liver(control), 23 cirrhotic liver, and 21 hepatocellular carcinoma. The results are summarized as follows: 1) The mean number of AgNORs per nucleus(mAgNOR) of normal liver, cirrhotic liver and hepatocellular carcinoma was 1.45+/-0.07, 2.53+/-0.38 and 5.52+/-1.63, respectively. The difference of mAgNOR between normal and cirrhotic liver, and between cirrhotic liver and hepatocellular carcinoma was statistically significant, respectively(p<0.01). 2) The percentage of nuclei showing five or more AgNORs per nucleus(pAgNOR) was 0.07% in normal liver, 7.59% in cirrhotic liver, and 60.49% in hepatocellular carcinoma. 3) AgNORs in hepatocellular carcinoma were large, pleomorphic and irregularly clumped, in addition to increase of mAgNOR and high pAgNOR. In conclusion, the increase of mAgNOR, high pAgNOR and large, irregular AgNORs are regarded as an additional helpful finding for the histopathological diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
8.Effect of transarterial chemoembolization in postoperative recurrent hepatocellular carcinoma.
Joon Koo HAN ; Jae Hyung PARK ; Ho Chul KIM ; Hyun Kyung LEE ; Byung Ihn CHOI ; Man Chung HAN ; Dong Young NOH ; Soo Tae KIM
Journal of the Korean Radiological Society 1991;27(4):453-457
No abstract available.
Carcinoma, Hepatocellular*
9.Analysis of therapeutic effects of transarterial chemoembolization in hepatocellular carcinoma.
Myung Sook LEE ; Eun Joo AN ; Eun Chul CHUNG ; Jung Soo SUH ; Chung Sik RHEE
Journal of the Korean Radiological Society 1991;27(4):447-452
No abstract available.
Carcinoma, Hepatocellular*
10.CT findings in ruptured hepatocellular carcinoma.
Sun Hee KIM ; Ki Whang KIM ; Jong Tae LEE ; Hyung Sik YOO
Journal of the Korean Radiological Society 1991;27(1):99-104
No abstract available.
Carcinoma, Hepatocellular*